Cathy Gwin
Senior Director, Communications
News
Media Contact
New NTI Framework Tackles Misuse Risks in AIxBio Tools
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
NTI Welcomes Christine E. Wormuth as President and CEO
A national security leader with more than 30 years of experience in defense policy, strategic planning, and international security, Secretary Wormuth brings an extensive record of leadership and service at the Department of Defense, the White House, and prominent think tanks.
NTI Supports Tech-Driven Solutions to Modernize BWC Compliance
At the UN General Assembly President Trump announced his administration’s intention to harness artificial intelligence to help uphold the international ban on biological weapons. Using advanced technology to strengthen the Biological Weapons Convention is a promising step and an approach NTI has long supported.
NTI at the Biological Weapons Convention: Urging Collective Action to Reduce Biological and AI Risks
NTI’s Global Biological Policy and Programs team will host two side events at the Sixth Session of the Working Group on the Strengthening of the Biological Weapons Convention (BWC).
NTI Advances Biotechnology Governance Framework to Reduce Emerging Biological Risks
NTI | bio convened global experts for the 2025 Biosecurity Innovation Risk Reduction Initiative (BIRRI) meeting to discuss safeguarding rapidly advancing bioscience and biotechnology capabilities, focusing on three key areas: DNA synthesis screening, safeguarding AIxBio capabilities, and guarding against mirror life risks.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
